This program combines the frequencies of peptides and a new form of frequencies called the Resonant Recognition Model. Bacteria Detox 3 is beneficial for Lyme disease, arthritis, respiratory, dental, and heart challenges.
NOTE: It is recommended to do the Peptide Detox, Deep Detox, and Virus Detox 1 before beginning a Bacteria Detox Program. If a specific health condition requires immediate attention due to bacterial overload, Bacteria Detox 1, 2, 3, or 4 may be selected first, provided the detox pathways have been previously cleared by the Peptide Detox and/or Deep Detox programs. Virus Detox programs should still be addressed, as viruses compromise the immune system by being latent in the background, making the body susceptible to bacterial reinfection.
Bacteria Detox 3
Antibacterial (General)
Peptides exhibit general antibacterial activity against gram-negative and gram-positive bacteria, including membrane disruption, pore formation, inhibition of cell wall synthesis, immunomodulation, and intracellular targeting mechanisms.
Brucellosis
Brucellosis is a zoonotic intracellular bacterial infection caused primarily by Brucella melitensis, B. abortus, B. suis, and B. canis. It manifests as undulant fever, sweats, arthralgia, hepatosplenomegaly, and can progress to chronic osteoarticular, cardiovascular, or neurologic complications.
Peptides address antioxidant protection, immune system protection, T-cell formation, reduction of invasion and intracellular replication, and effective autophagy.
Diphtheria (respiratory)
Diphtheria is an acute bacterial infection caused by toxigenic strains of Corynebacterium diphtheriae, with the primary virulence factor being diphtheria toxin (DT), which inhibits protein synthesis in host cells.
Peptides address bacterial clearance, inhibition of diphtheria toxin cytotoxicity, prevention of toxin-receptor interaction, antimicrobial activity against Corynebacterium diphtheriae, and direct membrane disruption of gram-positive bacteria.
Gram-Negative Bacterial Infection
Peptides address gram-negative bacterial infections, immunomodulation, innate immunity against gram-negative bacteria, anti-biofilm activity, endotoxin neutralization, anti-inflammatory effects, regulation of cytokine production, quorum-sensing disruption, antibiotic potentiation, and host cell protection.
Lyme Co-Infections
Lyme Co-infections (Bartonella, Borrelia species, Tick-Borne Relapsing Fever, Babesiosis, Human Granulocytic Anaplasmosis, etc.) Lyme co-infections encompass persistent tick-borne bacterial (Borrelia, Bartonella, Anaplasma) and protozoal (Babesia) pathogens causing immune evasion, chronic inflammation, biofilm formation, intracellular survival, and multi-tissue damage.
Peptides address antimicrobial action, inflammation, Borrelia/Bartonella inhibition, direct killing of Borrelia forms, Bartonella, anti-biofilm activity, immune enhancement for chronic infection clearance, systemic healing, and inflammation resolution, tissue integrity, angiogenesis, and counter persistent inflammation.
Meningitis
Peptides address antimicrobial properties to combat bacterial infection, anti-inflammatory properties to reduce neuroinflammation, vasoactive properties to manage pressure, immunomodulatory properties to balance immune response, and tissue repair to protect neural tissue.
MRSA Infection
Methicillin-resistant Staphylococcus aureus (MRSA) infection is a bacterial condition caused by strains of Staphylococcus aureus that have developed resistance to beta-lactam antibiotics, including methicillin, through acquisition of the mecA gene encoding penicillin-binding protein 2a (PBP2a), which reduces affinity for these drugs. MRSA can cause a spectrum of illnesses ranging from mild skin and soft tissue infections, such as boils, abscesses, and cellulitis, to severe invasive diseases like pneumonia, bacteremia, endocarditis, osteomyelitis, and septic arthritis.
Peptides address direct antimicrobial action via membrane and biofilm disruption to kill bacteria, iron chelation to limit nutrient availability and growth, and immune modulation to enhance host clearance and counteract evasion.
Mycoplasma Synoviae (Bacterial Arthritis)
Peptides address antimicrobial activity to inhibit bacterial growth, disruption of bacterial membranes, reduction of inflammation in joints, immunomodulation to enhance host defense, promotion of tissue repair in affected areas, and mitigation of oxidative stress associated with infection.
Mycoplasma Pneumoniae
Mycoplasma pneumoniae is a bacterial pathogen causing atypical pneumonia, respiratory tract infections, and sometimes extrapulmonary manifestations such as neurological or dermatological issues. Peptides address antimicrobial action against the pathogen, biofilm disruption, antioxidant coverage, immunomodulation to enhance host defense, anti-inflammatory effects to reduce lung damage, and support for respiratory tissue repair.
Pneumonia
Pneumonia involves alveolar infection, inflammation, and potential sepsis. Peptides address direct bactericidal action by disrupting microbial membranes, modulating the host immune response to prevent cytokine storms and protect lung epithelium, macrophage phagocytosis specifically in pneumococcal models, multi-drug-resistant respiratory pathogens, tissue repair, preventing acute lung injury and excessive inflammation, and destabilizing bacterial biofilms within the respiratory tract.
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever is a severe, potentially fatal tick-borne illness caused by the obligate intracellular bacterium Rickettsia rickettsii, leading to vasculitis, endothelial damage, rash, fever, and multi-organ failure if untreated.
Peptides address immunity induction, antimicrobial protection, endothelial protection, inflammation reduction, and oxidative stress suppression.
Staphylococcal Infection
Staphylococcal infections, commonly caused by Staphylococcus aureus (including MRSA strains), encompass skin and soft tissue infections, abscesses, pneumonia, bacteremia, and device-related infections, complicated by biofilm formation and antibiotic resistance.
Peptides address antimicrobial direct bacterial killing, biofilm disruption, intracellular targeting, immunomodulation, bacterial membrane disruption, and anti-staphylococcal effects.
Streptococcus A Infection
Streptococcus A Infection refers to diseases caused by Group A Streptococcus (Streptococcus pyogenes), ranging from mild (pharyngitis, impetigo) to severe invasive (necrotizing fasciitis, streptococcal toxic shock syndrome) and postinfectious complications. Complications involve tissue damage and hyperinflammation, protease-mediated immune evasion, antimicrobial peptide resistance, phagocytosis evasion, and cytokine storm.
Peptides address inflammatory responses, hyperinflammation modulation, cytokine storm mitigation, antimicrobial killing action, anti-virulence, immunomodulation, enhanced antitoxin, anti-adhesion, and direct membrane-disrupting activity.
Tetanus
Tetanus is an acute, often fatal neurological disorder caused by tetanospasmin toxin produced by Clostridium tetani, leading to severe muscle spasms, rigidity, autonomic instability, and neuronal excitotoxicity, typically 1633 entering through wounds. Peptides address antibacterial support, neurotoxin mitigation, inflammation control, muscle modulation, tissue protection, cytokine-mediated exacerbation, spasms, and neuronal uptake inhibition to aid immune clearance, symptom alleviation, and recovery.
Whooping Cough (Pertussis)
Whooping Cough is a highly contagious bacterial infection caused by Bordetella pertussis, featuring paroxysmal coughing, inspiratory whoop, and potential complications like apnea or seizures, primarily affecting infants and unvaccinated individuals. Peptides address pertussis toxin inhibition to mitigate neural damage, host immune modulation to balance cytokine and leukocyte responses, airway epithelium protection to limit mucin hypersecretion, cough mechanism modulation to alleviate paroxysms, anti-inflammatory effects to decrease inflammation, targeting bacterial persistence via eosinophil modulation, and direct antimicrobial activity against B. pertussis.
Bacterial Endocarditis
Bacterial endocarditis (BE) is a life-threatening infection of the endocardial surface, typically involving heart valves, caused predominantly by Gram-positive bacteria such as Staphylococcus aureus, Streptococcus spp., and Enterococcus spp. Key complications include valve destruction, embolization, heart failure, and immune-mediated sequelae like glomerulonephritis.
Peptides address BE through direct bactericidal activity against causal pathogens, enzymatic and electrostatic biofilm disruption, inhibition of bacterial adhesion to damaged valves, pro-resolution immunomodulation to limit tissue injury, regulation of neutrophil extracellular traps (NETs) to reduce thrombogenicity, endothelial protection and regeneration, antiplatelet effects to diminish vegetation growth, eradication of metabolically dormant persister cells, neutralization of key virulence factors like α-hemolysin, and inhibition to curb excessive inflammation.
Resonant Recognition Model (RRM)
RRM frequencies offer a new way to address how proteins and other molecules in living things interact. Proteins are long chains of building blocks, and each chain has a hidden pattern that acts like a specific radio frequency. Just as radios tune into the same station to play the same song, proteins with matching frequencies can “hear” each other and work together, even from a distance.
In this model, the protein’s chain is converted into a series of special numbers, based on how electrons move in each building block. These numbers form a signal, similar to a sound wave. By analyzing that signal, we can identify the main frequency, which is like the dominant note in a chord. Proteins that share the same dominant note are more likely to connect for tasks like fighting infections or sending signals in the body.
Here, the frequency comes from the molecule’s overall makeup, much like how different materials in a bell produce different rings. This helps predict if a substance will interfere with a protein’s frequency, blocking negative effects, such as in bacteria. RRM is a tool to design better results by matching or disrupting energy patterns.
RRM frequencies address:
Emotional Balance
Peptides effectively manage stress, anxiety, and emotional responses, thereby promoting overall mental well-being. Emotional disruptions and imbalances can lead to conditions such as anxiety disorders, depression, or chronic stress. Peptides facilitate emotional balance by modulating neurotransmitter release (serotonin, dopamine, GABA), hormonal regulation (Hypothalamic-Pituitary-Adrenal axis via cortisol), neuropeptide signaling for social interaction, anxiety reduction, stress resilience, neuroprotection, anti-inflammatory effects, mood and pain-related emotions, and sleep regulation.
NOTE: Peptide programs were developed over eight years of research to support molecular-level frequency work. Peptide frequencies offer multitudes of benefits for the body. A particular peptide may be in a certain program for its medically researched and acknowledged benefits for a particular challenge, and it may also help in many other areas of the body. If your body doesn’t require the benefit of a particular peptide in frequency form, that peptide will not do anything for you and will not have any negative effect.